03/11/2021
The Therapeutic Goods Administration (TGA) in Australia has added Bharat Biotech's Covid-19 vaccine Covaxin to its list of Covid-19 vaccines not registered in Australia but used widely internationally for the purpose of establishing a traveller's vaccination status.
With this, Covaxin & Covishield of India and Coronavac & BBIBP-CorV of China, both have been recognised by Australia, which houses a significant number of international students, skilled & non-skilled workers from both the Asian countries.
Covaxin is India's first indigenous Covid-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). So far, countries including Mauritius, Oman, Philippines, Nepal, Mexico, Iran, Sri Lanka, Greece, Estonia & Zimbabwe have recognised Covaxin.